May 8, 2009 (Chicago, Illinois) — Findings from a small preliminary study indicate that the number of trophoblast cells collected by Papanicolaou (Pap) test in the first trimester of pregnancy can ...

Sacituzumab govitecan (SG), a first-in-class anti–trophoblast cell surface antigen 2 (Trop-2) antibody-drug conjugate, demonstrated superior efficacy over single-agent chemotherapy (treatment of ...

Scientists have derived and grown trophoblast stem cells for the first time, which will lead to better understanding of the human placenta. In a milestone achievement for better understanding the ...

In the human placenta, there are placental villi, and the surface of the villi consists of syncytiotrophoblast, also called barrier cells, that serve as the main barrier against foreign substances.

We retrospectively analyzed 11 TACC specimens from the pathology archives of two Italian cancer reference centers. TROP-2 expression was assessed in all cases using immunohistochemistry.

Conventional human pluripotent stem cells at the primed pluripotent state are capable of generating all the embryonic lineages. However, their extraembryonic trophectoderm potentials is limited. It ...